Ophthalmic Surgical Instruments Market Report 2026

The ophthalmic surgical instruments market size has grown strongly in recent years. It will grow from $11.32 billion in 2025 to $12.04 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to traditional surgical instruments with limited precision, increasing prevalence of cataract and glaucoma, reliance on manual microsurgical tools, growing number of ophthalmic surgeries, lack of advanced intraocular lens options.

The ophthalmic surgical instruments market size is expected to see strong growth in the next few years. It will grow to $15.26 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to advancements in phacoemulsification technologies, increasing adoption of laser-assisted ophthalmic procedures, demand for digital ophthalmic microscopes, growth in multifocal and accommodative intraocular lens usage, rising focus on minimally invasive ophthalmic surgeries. Major trends in the forecast period include rising adoption of phacoemulsification instruments for cataract surgery, increasing integration of advanced illumination devices in operating rooms, growing demand for intraocular lenses with multifocal and toric designs, expansion of viscoelastic devices and balanced salt solutions usage, rising requirement for specialized surgical accessories and microsurgical tools.

The rising prevalence of eye diseases is expected to drive growth in the ophthalmic surgical instruments market in the coming years. Factors contributing to this increase include aging populations, lifestyle habits such as prolonged screen exposure, and environmental influences like pollution. Ophthalmic surgical instruments are essential for diagnosing, treating, and managing various eye conditions by enabling precise procedures on the eye’s delicate structures. For example, in May 2024, according to the Centers for Disease Control and Prevention, approximately 17.2% of Americans aged 40 and older - around 20.5 million people - had cataracts in at least one eye, with projections indicating this number could exceed 30 million by 2028. This growing prevalence of eye diseases is fueling the demand for ophthalmic surgical instruments.

Leading companies in the ophthalmic surgical instruments market are emphasizing technological innovations, such as bladeless excisional devices, to improve surgical accuracy, enhance safety, and minimize tissue trauma. Unlike traditional blades, bladeless excisional devices use a grasping or microengineered mechanism to allow smoother tissue removal, greater control, and reduced risk of accidental damage. For instance, in April 2025, Sight Sciences, a U.S.-based eye care technology company, introduced the OMNI Edge Surgical System for minimally invasive glaucoma surgery (MIGS). The system performs canaloplasty and trabeculotomy using the patented TruSync technology, which synchronizes viscoelastic delivery with surgical rotation to improve precision and reproducibility. The OMNI Edge supports safe, single-use procedures, addresses three major points of aqueous outflow resistance, and helps optimize intraocular pressure management in glaucoma patients.

In April 2024, Carl Zeiss Meditec AG, a Germany-based provider of ophthalmic medical devices, surgical microscopes, intraocular lenses, and visualization systems, acquired Dutch Ophthalmic Research Center (D.O.R.C.) for an undisclosed sum. This acquisition allows Zeiss to expand its offerings in vitreoretinal and cataract surgery by incorporating D.O.R.C.’s EVA NEXUS™ platform along with its extensive range of ophthalmic surgical instruments, consumables, and liquids. D.O.R.C., based in the Netherlands, specializes in equipment, surgical instruments, and consumables for ophthalmic procedures.

Major companies operating in the ophthalmic surgical instruments market are Johnson & Johnson, Alcon Inc., Hoya Corporation, Carl Zeiss Meditec AG, Santen Pharmaceutical, Corza Ophthalmology, Lumenis, Haag-Streit Group, Accutome Inc., Millennium Surgical Corp, Appasamy Associates, Tomey Corporation, IndoSurgicals, Microtrack Surgicals, INKA Surgical Instruments, Surgical Holdings, Devine Meditech, Ambler Surgical, ASICO LLC, Topcon Corporation, NIDEK Co Ltd, OCULUS Optikgeräte GmbH, Ziemer Ophthalmic Systems AG, Kowa Company Ltd.

North America was the largest region in the ophthalmic surgical instruments market in 2025. The regions covered in the ophthalmic surgical instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ophthalmic surgical instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the ophthalmic surgical instruments market by increasing the cost of imported microscopes, lasers, intraocular lenses, and surgical accessories. Hospitals, clinics, and ambulatory surgery centers in north america, europe, and asia-pacific are most affected due to high dependency on imported equipment. However, tariffs also encourage local manufacturing and assembly, promote cost-effective production of ophthalmic instruments, and drive innovation in precision surgical tools for cataract and glaucoma procedures.

The ophthalmic surgical instruments market research report is one of a series of new reports that provides ophthalmic surgical instruments market statistics, including ophthalmic surgical instruments industry global market size, regional shares, competitors with a ophthalmic surgical instruments market share, detailed ophthalmic surgical instruments market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic surgical instruments industry. This ophthalmic surgical instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Ophthalmic surgical instruments are specialized tools used in eye surgery to perform procedures such as cataract removal, corneal transplants, retinal surgery, and more. These instruments are designed to be precise, delicate, and safe for use within the small and sensitive environment of the human eye.

The main product types in ophthalmic surgical instruments include microscopes, illumination devices, phacoemulsification instruments, lasers, intraocular lenses, shunts and related drainage devices, viscoelastic devices, and surgical accessories. Microscopes in ophthalmic surgery provide high magnification of the eye, enabling surgeons to perform delicate procedures with precision. These instruments are applied in surgeries such as cataract surgery, glaucoma surgery, refractive surgery, vitreoretinal surgery, and others, and are used by hospitals, clinics, ambulatory surgery centers, and other healthcare facilities.

The ophthalmic surgical instruments market consists of sales of needle holders, knives, cannulas, forceps, and phacoemulsification systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.